Microbiological profile of ozenoxacin

dc.contributor.authorMorrissey, Ian
dc.contributor.authorCantón, Rafael
dc.contributor.authorVila Estapé, Jordi
dc.contributor.authorGargallo Viola, Domingo
dc.contributor.authorZsolt, Ilonka
dc.contributor.authorGarcía Castillo, María
dc.contributor.authorLópez, Yuly
dc.date.accessioned2019-06-18T15:22:25Z
dc.date.available2019-06-18T15:22:25Z
dc.date.issued2019-05-28
dc.date.updated2019-06-14T09:57:25Z
dc.description.abstractAim: To explore the antibacterial spectrum of ozenoxacin and compare its in vitro activity with that of other antibacterial agents. Materials & methods: In 2010, 10,054 isolates were collected from 128 centers worldwide. Minimum inhibitory concentrations against Gram-positive and Gram-negative isolates were determined for 23 and 13 antibacterial agents, respectively. Results: Ozenoxacin exhibited high in vitro activity against susceptible, and methicillin- or levofloxacin-resistant, Gram-positive bacteria. Ozenoxacin was one or two dilutions less active against Enterobacteriaceae isolates, except for Escherichia coli, than other quinolones. Conclusion: Ozenoxacin is a potent antimicrobial agent mainly against susceptible and resistant strains of Gram-positive isolates (staphylococci and streptococci), and shows activity against some Gram-negative isolates.
dc.format.extent15 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1746-0913
dc.identifier.urihttps://hdl.handle.net/2445/135343
dc.language.isoeng
dc.publisherFuture Science Group
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.2217/fmb-2019-0089
dc.relation.ispartofFuture Microbiology, 2019
dc.relation.urihttp://dx.doi.org/ 10.2217/fmb-2019-0089
dc.rightscc by-nc-nd (c) Morrissey et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationInfeccions respiratòries
dc.subject.classificationAntibiòtics
dc.subject.otherRespiratory infections
dc.subject.otherAntibiotics
dc.titleMicrobiological profile of ozenoxacin
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
MorrisseyI_Future_Microbiol_2019.pdf
Mida:
1.29 MB
Format:
Adobe Portable Document Format